Zynyz is the first and only FDA-approved first-line treatment for adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal.

Jørgensen will step down after eight years as CEO, with a successor search underway while the company reaffirms confidence in ...

Our exclusive poll captures today's top trends and perspectives—shaped by those pharma decision-makers impacted the most.

Leandro Boer, MD, PhD, VP, US general medicines, Amgen, discusses how new findings highlight the need for simplified decision-making in lipid management and a stronger focus on achieving LDL-C targets ...

Nigel McCracken, chief operating officer, Virax Biolabs explains how the ViraxImmune PAIS assay uses T cell responses and cytokine levels to detect immune dysfunction and identify viral triggers of ...

With combined investments exceeding $53 billion, both companies are deepening their US presence through expanded biologics production, gene therapy capabilities, and next generation R&D centers. A Q&A ...

Patients Getting Weight Loss Information from Advertising as Opposed to Doctors: New Study Suggests ...

Patients Getting Weight Loss Information from Advertising as Opposed to Doctors: New Study Suggests ...

Patients Getting Weight Loss Information from Advertising as Opposed to Doctors: New Study Suggests ...

Patients Getting Weight Loss Information from Advertising as Opposed to Doctors: New Study Suggests ...

Patients Getting Weight Loss Information from Advertising as Opposed to Doctors: New Study Suggests ...

Patients Getting Weight Loss Information from Advertising as Opposed to Doctors: New Study Suggests ...